Tag Archive for Initiative

Mesothelioma Victims Center Dramatically Expands It’s Mesothelioma Victims Initiative For All US Victims Including Plumbers, Electricians, Shipyard & Power Plant Workers

Mesothelioma Victims Center Dramatically Expands It’s Mesothelioma Victims Initiative For All US Victims Including Plumbers, Electricians, Shipyard & Power Plant Workers












(PRWEB) January 19, 2012

The Mesothelioma Victims Center is dramatically expanding its mesothelioma victims initiative to make certain they are talking to every US citizen, or every US family trying to figure out what to do after a mesothelioma diagnosis. While the group is by far the best branded mesothelioma victims advocate, for US Navy Veterans diagnosed with this rare form of cancer, they want to make certain every US citizen is aware of their unsurpassed services. This includes any plumber, electrician, power plant employee, shipyard worker, oil refinery worker, railroad employee, demolition contractor, city, or county water works employee, or auto brake technicians, or any US citizen, who could have been exposed to asbestos. The group says, “We have created a Mesothelioma Victims Bill of Rights, as part of our 2012 mesothelioma cancer victims initiative, that is both unequaled with respect to the quality of the service, but as, or more importantly every mesothelioma victim, or family dealing with this rare form of cancer is provided with the absolute best resources. If a victim of mesothelioma, or their families are concerned about compensation for mesothelioma, we will provide a victim, or their family with the names, and specific contacts for the best mesothelioma attorneys in the nation. If a family is concerned about mesothelioma cancer treatment options, we will hand craft a mesothelioma cancer treatment options report, that is tailor suited for the individual with mesothelioma, and highlights the best mesothelioma cancer treatment physicians, or medical practice groups, in the specific area, or region of the victim. No other group in the nation offers services like these. If you want the best possible service when dealing with a mesothelioma diagnosis call us anytime at 866-714-6466, and please allow us the opportunity to offer real help, and the best possible resources.” http://MesotheliomaVictimsCenter.Com

The Mesothelioma Victim Center’s Bill of Rights includes:

The names and specific contacts for the most successful, and reputable mesothelioma attorneys, or mesothelioma trial lawyers in the United States. The Mesothelioma Victims Center says, “There really can be a huge difference between getting a second, or third string mesothelioma personal injury attorney, and or getting the absolute best mesothelioma attorneys in the United States, when it comes to compensation. We recommend, and provide the specific contacts for the best, and the most capable mesothelioma attorneys in the US. No other group offers this vital service.”

*A customized mesothelioma cancer treatment options report, that is designed to identify the best mesothelioma cancer treatment options, in the specific area, region, and nation for a victim of mesothelioma.

The Mesothelioma Victims Center will always be on call to any family dealing with mesothelioma. This includes assisting a family with how to live with mesothelioma, assistance with hospice, or any other need they may have.

Individuals, or families dealing with a mesothelioma diagnosis, or living with mesothelioma are encouraged to contact the Mesothelioma Victims Center anytime at 866-714-6466 for their unparalleled free services. http://MesotheliomaVictimsCenter.Com

# # #









Attachments






















Vocus©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.







Greater Zurich Area AG and Swiss Biotech See Solid Swiss Biotech Growth, Announce New Life Sciences Initiative and Booklet

Greater Zurich Area AG and Swiss Biotech See Solid Swiss Biotech Growth, Announce New Life Sciences Initiative and Booklet











Zurich, Switzerland and San Diego, CA (PRWEB) June 12, 2008

Switzerland’s biotech sector enjoyed healthy growth in 2007, according to the latest annual report of Swiss Biotech, the biotech consortium of Switzerland. In addition, the Greater Zurich Area AG has published “Life Science Zurich” a comprehensive guide to the life sciences sector in the Greater Zurich Area, a thriving location for R&D, investing and business in Swiss biotech and life sciences.

During the run-up for the BIO 2008 in San Diego, Swiss Biotech, the national biotech consortium of Switzerland, has released its annual report. The Swiss Biotech Report 2008 gathers the key economic data of the Swiss biotechnology industry for the year 2007. Market indicators point to double-digit growth in many key areas and suggest that Switzerland has expanded its role and reputation as a hotbed for biotech and life sciences.

Swiss Biotech represents currently 220 Swiss biotech companies, divided into 148 biotech developers and 72 biotech suppliers (multinational pharma companies and their subsidiaries are not counted).

In the wake of Swiss market leaders such as Roche and Novartis, core biotech business activities predominantly take place in red biotechnology, i.e. human and veterinary medicine.

White (environmental and industry processes) and green biotech (agriculture and food) have great upward potential. A point in case is the recent opening of EMEA headquarters by food, cleaning and health product and service provider Ecolab Inc. in the Greater Zurich Area.

Swiss biotech industry results

Key figures of the Swiss biotech industry in 2007 include:


Industry turnover increased by 10.8% in 2007, to CHF 7,116 million (2006: CHF 6,424 million).
Number of Swiss biotech employees increased by 10% across the industry.
R&D investment by private and listed companies increased by 6%, to CHF 1’696 million (2006: CHF 1,600 million).
Investments by new investors increased by 13.5%, to CHF 885 million (2006: CHF 780 million).
Private equity increased by nearly 10% to 246 million (2006: CHF 224 million).
SWX Swiss Exchange saw a CHF 137 million IPO by Addex Pharmaceuticals (the biggest in Europe in 2007) that made for a successful year at SXI LIFE SCIENCES® and SXI Bio+Medtech indices (despite the acquisition of Swiss Serono by industry leader Merck).

Investment across the board, full product pipelines

Investments in Swiss biotech are not limited to big companies in European pharma. “It is remarkable that relatively small young companies, which only have some preclinical products so far, achieved some of the larger financing rounds”, states Dr med Yvonne Gunsch-Wegmann, Head of Issuer & Investor Relations, SWX Swiss Exchange.

R&D investments are yielding positive results on the product side. “There are more than enough products in the pipeline and the sector can look to the future with confidence”, said Jürg Zürcher, partner and biotechnology leader for Central Europe with Ernst & Young.

Life Science Zurich booklet launched

The optimistic outlook is a consequence of Switzerland’s commitment to excellent infrastructure for top-notch R&D. Due to a high density of academic, engineering and corporate institutions as well as high levels of public and private funding, researchers and entrepreneurs see great opportunities when it comes to biotech in Switzerland.

A prime example is the Greater Zurich Area, home to the ETH Zurich and the University of Zurich, two pre-eminent universities of continental Europe. Here, basic biotech research is complemented by a plethora of interdisciplinary knowledge in life sciences and generated in research projects, think tanks, and competence centers. Relationships between scientific and business expertise are facilitated and enhanced through dedicated technology transfer offices such as Unitectra and business promotions such as the “Life Science Zurich” initiative.

To provide a comprehensive overview about the life sciences and biotech niche in this powerful Swiss economic region, the Greater Zurich Area AG has published the compendium “Life Science Zurich”. Issues will be available at the BIO 2008 in San Diego through the Greater Zurich Area AG.

About Swiss Biotech

The Swiss Biotech label was created in order to bolster the Swiss biotech scene at home and abroad and to ensure a uniform image. Swiss Biotech is a consortium of the Swiss biotech regions Bioalps, Biopolo, BaselArea and the Greater Zurich Area. Further members of this marketing alliance are SWX Swiss Exchange, the Swiss Biotech Association and the Medical Cluster.

http://www.swissbiotech.org

About the Greater Zurich Area AG

The Greater Zurich Area AG, a nonprofit organization, is the marketing association for the Greater Zurich Area business region. It recruits international companies abroad and assists them with setting up companies and making investments in the Greater Zurich Area. Its sponsor is the “Stiftung Greater Zurich Area Standortmarketing,” a public-private partnership that was established in November 1998. Since that time, its membership has grown to include the cantons of Aargau, Glarus, Graubünden, Schaffhausen, Schwyz, Solothurn and Zürich, the cities of Zürich and Winterthur, and several businesses.

http://www.greaterzuricharea.ch

Swiss Biotech and the Greater Zurich Area AG at the BIO 2008

Swiss Biotech and the Greater Zurich Area AG are located at the Swiss Pavilion in booth no. 3745. Join us to learn more about the renowned research institutions, scientific talent, investment opportunities and professional services that distinguish Switzerland’s Biotech Industry.

http://www.swissbiotech.org

For further information, to order the Swiss Biotech Report 2008 and Life Science Zurich booklet, please contact:

Lukas Huber, Director Life Sciences and VP Swiss Biotech,

Greater Zurich Area AG

Limmatquai 112, 8001 Zürich / Switzerland

Phone +41 44 254 59 08

lukas.huber(at)greaterzuricharea.ch

Marc Neumann, International Media Relations,

Greater Zurich Area AG, New York

Phone +1 917 330 9476

marc.neumann(at)greaterzuricharea.ch

###









Attachments


















Vocus©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.